Farmasiet extends its partnership with Peptonic Medical, bringing VagVital's product portfolio to Norway

Peptonic Medical AB (publ) (“Peptonic”) is extending the partnership with Farmasiet that will bring the entire VagVital product portfolio to the Norwegian market. Farmasiet, Norway's largest online pharmacy, is set to launch these innovative products designed to address specific needs in intimate care, encompassing diagnosis, treatment, and prevention. The introduction of VagVital products is scheduled to commence in early 2024. Vernivia is already available at Farmasiet.

By leveraging Farmasiet's robust presence in the Norwegian market and Peptonic Medical's scientific expertise, this extension marks a significant step in providing customers with high-quality intimate care solutions.

"I am excited to announce Peptonic Medical's extended partnership with Farmasiet, Norway's largest online pharmacy, as we now also introduce our comprehensive VagVital product range to the Norwegian market. Thus, this merges our scientific expertise in women's health with Farmasiet's expansive platform, enabling us to deliver high-quality intimate care solutions to a wider audience. We look forward to the opportunities this collaboration will unfold." - Fanny Falkman Grinndal, Business Manager Nordics.

For further information, please contact:

Fanny Falkman Grinndal, Business Manager Nordics

Phone: +46 70-196 17 97

Email: fanny.falkman-grinndal@peptonicmedical.se

About PEPTONIC medical AB

Peptonic Medical AB is an innovative Swedish biomedical company engaged in research, development, and sales of unique medical treatments in the field of women's intimate health. Under the brand VagiVital®, the product portfolio encompasses treatments for various conditions such as vaginal atrophy, bacterial vaginosis, and urinary tract infections. These clinically tested products address the growing demand for intimate self-care within the business concept of Diagnose, Treat, Prevent. Sweden serves as the reference market to facilitate geographic expansion in collaboration with local distributors. The United States is the largest market in terms of sales. The company is headquartered in Stockholm, Sweden, with a sales office in New York, NY, and an R&D unit in Caesarea, Israel. Peptonic Medical also has a wholly owned subsidiary, Lune Oy, in Finland, focusing on sustainable period products sold under the Lunette®️ brand (www.lunette.com). The company's shares have been listed on www.spotlightstockmarket.com since 2014.